Helix BioPharma Corp. total revenue, net income and dynamics of changes in US dollar today
Helix BioPharma Corp. current income in US dollar. The dynamics of Helix BioPharma Corp. net revenue grew by 0 $ compared to the previous report. Net income, revenue and dynamics - the main financial indicators of Helix BioPharma Corp.. Graph of the financial report of Helix BioPharma Corp.. The financial schedule of Helix BioPharma Corp. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The value of the "total revenue of Helix BioPharma Corp." on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/10/2019
0 $
-
-2 176 000 $
-
31/07/2019
0 $
-
-2 168 000 $
-
30/04/2019
0 $
-
-2 071 000 $
-
31/01/2019
0 $
-
-1 908 000 $
-
31/10/2018
0 $
-
-1 379 000 $
-
31/07/2018
0 $
-
-1 610 000 $
-
30/04/2018
0 $
-
-2 147 000 $
-
Show:
to
Helix BioPharma Corp. financial report charts
Dates of Helix BioPharma Corp. finance reports: 30/04/2018, 31/07/2019, 31/10/2019. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Helix BioPharma Corp. for today is 31/10/2019. Operating income Helix BioPharma Corp. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Helix BioPharma Corp. is -2 220 000 $
Helix BioPharma Corp. quarterly report dates
Net income Helix BioPharma Corp. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Helix BioPharma Corp. is -2 176 000 $ Current assets Helix BioPharma Corp. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Helix BioPharma Corp. is 2 199 000 $ Total assets Helix BioPharma Corp. refers to the total amount of assets owned by a person or entity. Total assets Helix BioPharma Corp. is 2 435 000 $
Current cash Helix BioPharma Corp. - the sum of all of the cash a company has on the date of report. Current cash Helix BioPharma Corp. is 1 650 000 $ Current debt Helix BioPharma Corp. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Helix BioPharma Corp. is 1 769 000 $ Total debt Helix BioPharma Corp. is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year. Total debt Helix BioPharma Corp. is 1 769 000 $
31/10/2019
31/07/2019
30/04/2019
31/01/2019
31/10/2018
31/07/2018
30/04/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-
-
-
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
-
-
-
-
-
-
-
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-2 220 000 $
-2 192 000 $
-2 050 000 $
-1 863 000 $
-1 387 000 $
-1 595 000 $
-2 121 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 176 000 $
-2 168 000 $
-2 071 000 $
-1 908 000 $
-1 379 000 $
-1 610 000 $
-2 147 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 511 000 $
1 311 000 $
1 351 000 $
1 330 000 $
1 014 000 $
989 000 $
1 435 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
2 220 000 $
2 192 000 $
2 050 000 $
1 863 000 $
1 387 000 $
1 595 000 $
2 121 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
2 199 000 $
687 000 $
1 316 000 $
883 000 $
1 434 000 $
773 000 $
1 306 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 435 000 $
940 000 $
1 599 000 $
1 195 000 $
1 780 000 $
1 147 000 $
1 714 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 650 000 $
206 000 $
938 000 $
306 000 $
871 000 $
366 000 $
770 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
1 769 000 $
4 221 000 $
3 519 000 $
2 881 000 $
3 431 000 $
2 674 000 $
3 221 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
1 769 000 $
4 221 000 $
3 519 000 $
2 881 000 $
3 431 000 $
2 674 000 $
3 221 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
72.65 %
449.04 %
220.08 %
241.09 %
192.75 %
233.13 %
187.92 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
45 000 $
-3 281 000 $
-1 920 000 $
-1 686 000 $
-1 651 000 $
-1 527 000 $
-1 507 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-4 647 000 $
-1 163 000 $
-1 197 000 $
-2 411 000 $
-760 000 $
-1 971 000 $
-1 320 000 $
Last revenue report of Helix BioPharma Corp. was 31/10/2019. According to last financial report total revenue in Helix BioPharma Corp. was 0 US dollar and changed by 0% since last year. Net income in Helix BioPharma Corp. was -2 176 000 $ in last quartal, net income changes to 0%.
Cash flow Helix BioPharma Corp. is the net amount of cash and cash-equivalents being transferred into and out of a business. Cash flow Helix BioPharma Corp. is -4 647 000 $
